|
|
|
Publicacions |
 |
Benito Menni CASM ha publicat nombrosos articles i llibres especialitzats, a més
de l’edició periòdica de la revista Informaciones Psiquiátricas
que podeu consultar a la web:
http://www.revistahospitalarias.org
A continuació posem a la vostra disposició la relació de les
publicacions recents.
Treballs publicats en revistes internacionals 2010
[1] Amann, B., C. Born, J.M. Crespo, E. Pomarol-Clotet, and P. McKenna Lamotrigine: when and where does it act in affective disorders? A systematic review. Neuroimage
Journal of Psychopharmacology (IF: 3.647), 2010.
[2] Bartz, J., D. Simeon, H. Hamilton, S. Kim, S. Crystal, A. Braun, V. Vicens, and E. Hollander Oxytocin can hinder trust and cooperation in borderline personality disorder.
Social Cognitive and Affective Neuroscience (IF: 4.203), 2010.
[3] Begum, M. and P.J. McKenna Olfactory reference syndrome: a systematic review of the world literature.
Psychological Medicine (IF: 5.012), 2010: p. 1-9.
[4] Bhatt, R., K.R. Laws, and P.J. McKenna False memory in schizophrenia patients with and without delusions.
Psychiatry Research (IF: 2.373), 2010. 178(2): p. 260-5.
[5] Delaveau, P., P. Salgado-Pineda, P. Fossati, T. Witjas, J.P. Azulay, and O. Blin Dopaminergic modulation of the default mode network in Parkinson's disease.
European Neuropsychopharmacology (IF: 3.684), 2010. 20(11): p. 784-92.
[6] Gomar, J.J., J. Ortiz-Gil, P.J. McKenna, R. Salvador, B. Sans-Sansa, S. Sarro, A. Guerrero, and E. Pomarol-Clotet Validation of the Word Accentuation Test (TAP) as a means of estimating premorbid IQ in Spanish speakers.
Schizophrenia Research (IF: 4.458), 2010.
[7] Gomar, J.J., E. Pomarol-Clotet, S. Sarro, R. Salvador, C.E. Myers, and P.J. McKenna Procedural learning in schizophrenia: reconciling the discrepant findings..
Biological Psychiatry (IF: 8.926), 2011. 69(1): p. 49-54.
[8] Iturria-Medina, Y., A.P. Fernandez, D.M. Morris, E.J. Canales-Rodriguez, H.A. Haroon, L.G. Penton, M. Augath, L.G. Garcia, N. Logothetis, G.J. Parker, and L. Melie-Garcia Brain Hemispheric Structural Efficiency and Interconnectivity Rightward Asymmetry in Human and Nonhuman Primates.
Cerebral Cortex (IF: 6.979), 2010.
[9] Jauhar, S., A. Blackett, P. Srireddy, and P.J. McKenna Pernicious anaemia presenting as catatonia without signs of anaemia or macrocytosis.
British Journal of Psychiatry (IF: 5.777), 2010. 197: p. 244-5.
[10] Lorente-Rovira, E., J.L. Santos-Gomez, M. Moro, J.M. Villagran, and P.J. McKenna Confabulation in schizophrenia: A neuropsychological study.
Journal of the International Neuropsychological Society (IF: 2.766), 2010: p. 1-9.
[11] Lynall, M.E., D.S. Bassett, R. Kerwin, P.J. McKenna, M. Kitzbichler, U. Muller, and E. Bullmore Functional Connectivity and Brain Networks in Schizophrenia.
Journal of Neuroscience (IF: 7.178), 2010. 30(28): p. 9477-9487.
[12] Mohino, S., A. Pujol, and I. Idiaquez Personality Disorders and Criminal Responsibility in the Spanish Supreme Court.
Journal of Forensic Sciences (IF: 1.524), 2011. 56(1): p. 150-154.
[13] Molinuevo, J.L., B. Gomez-Anson, G.C. Monte, B. Bosch, R. Sanchez-Valle, and L. Rami Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates.
Archives of Gerontology and Geriatrics (IF: 1.36), 2010.
[14] Musalek, M., V. Larach-Walters, J.P. Lepine, B. Millet, W. Gaebel, and P. (and McKenna) Psychopathology in the 21st century.
World Journal of Biological Psychiatry (IF: 5.564), 2010. 11(7): p. 844-51.
[15] Pomarol-Clotet, E., E.J. Canales-Rodriguez, R. Salvador, S. Sarro, J.J. Gomar, F. Vila, J. Ortiz-Gil, Y. Iturria-Medina, A. Capdevila, and P.J. McKenna Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging.
Molecular Psychiatry (IF: 15.049), 2010. 15(8): p. 823-30.
[16] Pomarol-Clotet, E., M. Fatjo-Vilas, P.J. McKenna, G.C. Monte, S. Sarro, J. Ortiz-Gil, C. Aguirre, J.J. Gomar, A. Guerrero, R. Landin, A. Capdevila, L. Fananas, and R. Salvador COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects.
Neuroimage (IF: 5.739), 2010. 53(3): p. 899-907.
[17] Popovic, D., M. Reinares, B. Amann, M. Salamero, and E. Vieta Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.
Psychopharmacology (IF: 4.103), 2010.
[18] Radua, J., E. Via, M. Catani, and D. Mataix-Cols Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls.
Psychological Medicine (IF: 5.012), 2010: p. 1-12.
[19] Salgado-Pineda, P., E. Fakra, P. Delaveau, P.J. McKenna, E. Pomarol-Clotet, and O. Blin Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients..
Schizophrenia Research (IF: 4.458), 2010.
[20] Salvador, R., M. Anguera, J.J. Gomar, E.T. Bullmore, and E. Pomarol-Clotet Conditional mutual information maps as descriptors of net connectivity levels in the brain.
Front Neuroinformatics, 2010. 4: p. 115.
[21] Salvador, R., S. Sarro, J.J. Gomar, J. Ortiz-Gil, F. Vila, A. Capdevila, E. Bullmore, P.J. McKenna, and E. Pomarol-Clotet Overall brain connectivity maps show cortico-subcortical abnormalities in schizophrenia.
Human Brain Mapping (IF: 6.256), 2010. 31(12): p. 2003-14.
[22] Zandi, M.S., S.R. Irani, B. Lang, P. Waters, P.B. Jones, P. McKenna, A.J. Coles, A. Vincent, and B.R. Lennox Disease-relevant autoantibodies in first episode schizophrenia.
Journal of Neurology (IF: 2.903), 2010.
[23] Ziauddeen, H., C. Dibben, C. Kipps, J.R. Hodges, and P.J. McKenna Negative schizophrenic symptoms and the frontal lobe syndrome: one and the same?.
European Archives of Psychiatry and Clinical Neuroscience (IF: 2.747), 2010.
Treballs publicats en revistes internacionals 2005-2006:
[1] Salvador R, Martinez A, Pomarol-Clotet E, Sarro S, Fletcher P, Bullmore ET. Frequency based mutual information measures between clusters
of brain regions in functional magnetic resonance imaging. Neuroimage
(2007), doi:101016/jneuroimage200612001. 2007.
[2] Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, et al.
A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant
Rapid-Cycling Bipolar Disorder. J Clin Psychopharmacol. 2007 Feb;27(1):104-6.
[3] Sterr A, Padberg F, Amann B, Mergl R, Mulert C, Juckel G, et al.
Electroencephalographic abnormalities associated with antidepressant treatment:
a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.
J Clin Psychiatry. 2006 Feb;67(2):325-6.
[4] Sterr A, Amann B, Grunze H. [Prophylaxis of bipolar
disorder]. Psychiatr Prax. 2006 Mar;33 Suppl 1:S47-54.
[5] Sarró S, Dueñas RM, Galve L, Mediavilla R, Mensa I, Sole J, et al.
Validación de la escala de Calgary en pacientes con esquizofrenia crónica.
Informaciones psiquiátricas. 2006;182(4):203-13.
[6] Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, et al.
Psychological effects of ketamine in healthy volunteers.
Phenomenological study. Br J Psychiatry. 2006 Aug;189:173-9.
[7] Parthasarathi UD, Harrower T, Tempest M, Hodges JR, Walsh C, McKenna PJ, et
al. Psychiatric presentation of voltage-gated potassium
channel antibody-associated encephalopathy. Case report. Br J Psychiatry.
2006 Aug;189:182-3.
[8] Menon M, Pomarol-Clotet E, McKenna PJ, McCarthy R.
Probabilistic reasoning in schizophrenia: A comparison of the performance of deluded
and nondeluded schizophrenic patients and exploration of posible ognitive underpinnings.
Cognitive Neuropsychiatry. 2006;11 (6):521-36.
[9] McKenna PJ. What works in schizophrenia: cognitive
behaviour therapy is not effective. BMJ. 2006 Aug 12;333(7563):353.
[10] Leeson VC, Laws KR, McKenna PJ. Formal thought disorder
is characterised by impaired lexical access. Schizophr Res. 2006 Dec;88(1-3):161-8.
[11] Honey GD, O'Loughlin C, Turner DC, Pomarol-Clotet E, Corlett PR, Fletcher PC.
The effects of a subpsychotic dose of ketamine on recognition
and source memory for agency: implications for pharmacological modelling of core
symptoms of schizophrenia. Neuropsychopharmacology. 2006 Feb;31(2):413-23.
[12] Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, et al.
Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
N Engl J Med. 2006 Feb 2;354(5):472-82.
[13] Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, et al.
Frontal responses during learning predict vulnerability
to the psychotogenic effects of ketamine: linking cognition, brain activity, and
psychosis. Arch Gen Psychiatry. 2006 Jun;63(6):611-21.
[14] Amann B, Sterr A, Vieta E, Stampfer R, Walden J, Grunze H.
An exploratory open trial on safety and efficacy of the anticonvulsant retigabine
in acute manic patients. J Clin Psychopharmacol. 2006 Oct;26(5):534-6.
[15] Templeman LA, Reynolds GP, Arranz B, San L. Polymorphisms
of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced
weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet
Genomics. 2005 Apr;15(4):195-200.
[16] San L, Arranz B, Escobar R. Pharmacological management
of acutely agitated schizophrenic patients. Curr Pharm Des. 2005;11(19):2471-7.
[17] Ros S, Aguera L, de la Gandara J, Rojo JE, de Pedro JM.
Potentiation strategies for treatment-resistant depression. Acta Psychiatr
Scand Suppl. 2005(428):14-24, 36.
[18] Rojo JE, Ros S, Aguera L, de la Gandara J, de Pedro JM.
Combined antidepressants: clinical experience. Acta Psychiatr Scand Suppl.
2005(428):25-31, 6.
[19] Rojo JE, Gibert K, Cobo J, Rodriguez-Cano E, Vallejo J.
Onset of antidepressant action: a pharmacological question? Hum Psychopharmacol.
2005 Aug;20(6):425-33.
[20] Orth M, Amann B, Robertson MM, Rothwell JC. Excitability
of motor cortex inhibitory circuits in Tourette syndrome before and after single
dose nicotine. Brain. 2005 Jun;128(Pt 6):1292-300.
[21] Orth M, Amann B, Ratnaraj N, Patsalos PN, Rothwell JC.
Caffeine has no effect on measures of cortical excitability. Clin Neurophysiol.
2005 Feb;116(2):308-14.
[22] Menon M, Woodward TS, Pomarol-Clotet E, McKenna PJ, McCarthy R.
Heightened stimulus salience renders deluded schizophrenics less susceptible to
the 'famous names illusion'. Schizophr Res. 2005 Dec 15;80(2-3):369-71.
[23] Leeson VC, Simpson A, McKenna PJ, Laws KR. Executive
inhibition and semantic association in schizophrenia. Schizophr Res.
2005 Apr 1;74(1):61-7.
[24] Leeson VC, McKenna PJ, Murray G, Kondel TK, Laws KR.
What happens to semantic memory when formal thought disorder remits? Revisiting
a case study. Cognit Neuropsychiatry. 2005 Jan;10(1):57-71.
[25] Leeson VC, McKenna PJ, Laws KR. Storage and access
procedures in schizophrenia: evidence for a two phase model of lexical impairment.
J Clin Exp Neuropsychol. 2005 Aug;27(6):700-10.
[26] Honey GD, Pomarol-Clotet E, Corlett PR, Honey RA, McKenna PJ, Bullmore ET,
et al. Functional dysconnectivity in schizophrenia associated
with attentional modulation of motor function. Brain. 2005 Nov;128(Pt
11):2597-611.
[27] Honey GD, Honey RA, Sharar SR, Turner DC, Pomarol-Clotet E, Kumaran D, et al.
Impairment of specific episodic memory processes by sub-psychotic
doses of ketamine: the effects of levels of processing at encoding and of the subsequent
retrieval task. Psychopharmacology (Berl). 2005 Sep;181(3):445-57.
[28] Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, et al.
Antiepileptic drugs in mood-disordered patients. Epilepsia. 2005;46 Suppl
4:38-44.
[29] Dibben CR, Kalavalapalli SS, Linnington HE, Hynes FA, Dinneen SF, Adler AI,
et al. Diabetes associated with atypical antipsychotic
treatment may be severe but reversible: case report. Int J Psychiatry
Med. 2005;35(3):307-11.
[30] de la Gandara J, Rojo JE, Ros S, Aguera L, de Pedro JM.
Neuropharmacological basis of combining antidepressants. Acta Psychiatr
Scand Suppl. 2005(428):11-3, 36.
[31] de la Gandara J, Aguera L, Rojo JE, Ros S, de Pedro JM.
Use of antidepressant combinations: which, when and why? Results of a Spanish survey.
Acta Psychiatr Scand Suppl. 2005(428):32-6.
[32] de la Gandara J, Aguera L, Rojo JE, Ros S. Working
group on combined antidepressants (G.E.A.A.: grupo para el estudio de las asociaciones
de antidepresivos). Acta Psychiatr Scand Suppl. 2005(428):5-6.
[33] Barrera A, McKenna PJ, Berrios GE. Formal thought
disorder in schizophrenia: an executive or a semantic deficit? Psychol
Med. 2005 Jan;35(1):121-32.
[34] Amann B, Sterr A, Mergl R, Dittmann S, Seemuller F, Dobmeier M, et al. Zotepine loading in acute and severely manic patients: a
pilot study. Bipolar Disord. 2005 Oct;7(5):471-6.
[35] Amann B, Grunze H. Neurochemical underpinnings in
bipolar disorder and epilepsy. Epilepsia. 2005;46 Suppl 4:26-30.
[36] Aguera LF, Rojo JE, Ros S, de la Gandara J, de Pedro JM.
Antidepressant combinations: epidemiological considerations. Acta Psychiatr
Scand Suppl. 2005(428):7-10, 36.
Llibres
[1] McKenna PJ. Schizophrenia and related syndromes.
2nd ed. Hove ; New York: Taylor & Francis 2007.
[2] McKenna PJ, Oh TM. Schizophrenic speech : making sense
of bathroots and ponds that fall in doorways.
Cambridge ; New York: Cambridge University Press 2005.
[3] McKenna PJ. Schizophrenia and related syndromes.
Oxford ; New York: Oxford University Press 1994.
|
|